Overview
- São Paulo civil police have formally indicted Goldman Sachs employees Felipe Guerra Acosta and Natan Lima Reinig on allegations they misrepresented stakes held through Josephina I, II and III to conceal true ownership of Oncoclinicas.
- Police say the Josephina vehicles were used to make it appear no single party crossed a 15% threshold in Oncoclinicas’ bylaws; that threshold would require a mandatory public tender offer, known in Brazil as an OPA.
- Public filings after Oncoclinicas’ 2021 listing attributed indirect ownership of the Josephina funds to Goldman Sachs while omitting U.S. manager Centaurus, whose November 2024 claim of indirect ownership later raised investor questions.
- The case is at the criminal-investigation stage with no court decision yet on whether the 15% rule was breached, and police estimate a court-ordered OPA would cost about R$6 billion, a sum that would directly affect shareholders.
- If prosecutors press charges and courts find a breach, the outcome could force a costly buyout for minority holders, expose Goldman Sachs to regulatory and reputational risk, and prompt scrutiny of fund disclosure practices in Brazil.